Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Moderna's wider-than-expected loss and soft guidance weigh on battered stock
06:38am, Friday, 14'th Feb 2025
COVID-19 vaccine sales topped consensus but RSV sales remain modest
Moderna posts bigger loss than expected as vaccine maker scales down manufacturing
06:34am, Friday, 14'th Feb 2025
Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid weakening demand for its COVID-19 vaccine.
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
06:28am, Friday, 14'th Feb 2025
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing
Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
02:15am, Friday, 14'th Feb 2025
Moderna, Inc. MRNA will release its fourth-quarter financial results, before the opening bell, on Friday, Feb. 14, 2025.
Insights Into Moderna (MRNA) Q4: Wall Street Projections for Key Metrics
10:20am, Tuesday, 11'th Feb 2025
Evaluate the expected performance of Moderna (MRNA) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?
02:46pm, Monday, 10'th Feb 2025
We focus on biotech stocks like VRTX, GILD, BIIB, ALNY and MRNA, which are scheduled to report this week.
2 Biotech Stocks to Buy Hand Over Fist in February
11:15am, Sunday, 09'th Feb 2025
Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the strategy for long-term investors remains the same: Invest in companies that can perform
3 Beaten-Down Stocks That Aren't Worth Buying on the Dip
11:57am, Saturday, 08'th Feb 2025
Buying stocks at significantly reduced valuations can lead to some incredible returns later on. But that doesn't mean that any stock down big is a good buy.
Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
11:00am, Friday, 07'th Feb 2025
Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards?
10:16am, Friday, 07'th Feb 2025
When MRNA reports fourth-quarter earnings, investors will likely focus on pipeline updates.
3 Top AI-Powered Biotech Stocks to Buy in February
09:45am, Thursday, 06'th Feb 2025
Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability to automate complex workflows and enhance productivity is seen as a game-ch
Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job
11:51am, Tuesday, 04'th Feb 2025
Shares of vaccine makers and packaged food companies fell on Tuesday after President Donald Trump's pick for U.S. health secretary, Robert F. Kennedy Jr., moved closer to the job after a favorable vot
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
11:50am, Tuesday, 04'th Feb 2025
Shares of vaccine companies fell after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services to the full chamber.
Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?
08:45am, Monday, 03'rd Feb 2025
Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.
5 Stocks Surging on DeepSeek's Shocking Week
12:00pm, Sunday, 02'nd Feb 2025
Euphoria in Silicon Valley turned to panic this week after a Chinese-based startup called DeepSeek released a new large language model (LLM). It's very good.
